As of June 2021, Semaglutide GLP-1 injections have been FDA-approved for weight loss rather than only the treatment of type 2 diabetes, but only for patients that qualify for the injections through a medical weight-loss program provided by a health care provider
This hormone helps regulate blood sugar levels, promotes insulin secretion, slows gastric emptying, and reduces appetite
Table of Contents: Do Semaglutide GLP-1 shots work for chronic weight loss
There is no confusion about which days are dose days
The new peptide, however, turned out to slow down the stomach's processing of food and cause weight loss (Winkler, Cohen)
Viking Therapeutics Today VKTX Viking Therapeutics $34.87 +0.08 (+0.23%) As of 07/27/2026 04:00 PM Eastern 52-Week Range $22.96 $43.15 Price Target $97.00 Viking is developing VK2735 in both oral and injectable forms and should begin Phase 3 trials for the oral form in the coming months